BioGaia and Nestlé Collaborate to Sell BioGaia Protectis Drops in Australia

674cdef2-c325-4bda-af7a-ff137cadef4barticleimage.png

17 Mar 2017 --- BioGaia has announced that its global collaboration with Nestlé has been extended, with the company signing an agreement with Nestlé Australia Ltd for the exclusive rights to sell BioGaia Protectis drops in Australia from 2017. 

The product will be co-branded under the BioGaia and Nestlé brands. 

“This exclusive agreement represents another positive development in the global partnership between Nestlé and BioGaia,” says Angela Lu, Business Executive Officer, Nestlé Infant Nutrition Oceania.

“The product is a natural extension to our existing portfolio, and further strengthens our nutritional offering across the crucial first 1000 days of an infant’s life.”

“This launch signifies the beginning of what we are sure will be a long and successful partnership.”

“We have had a collaboration with Nestlé since 2008, and this started in the infant formula field,” Axel Sjöblad, Managing Director of BioGaia AB tells NutritionInsight.

“This is a global agreement now that we have with them today, which is of course very good for Biogia, as we can benefit from a phenomenal global organization in many countries.”

“However, this new agreement that we have now signed in Australia is a local agreement that is more commercial, and focuses on our probiotic drops for the treatment of colic.”

Sjöblad explains that the launch is the first time the company has used the Biogia brand name in Australia.

“We have tried before, but not under own brand. For us this is a big step, and with the support of the nestle organization we can support the Biogia brand in this new territory.”

Entering a new market comes with new challenges, one that in this case, Sjöblad identifies as regulation.

“We can say that a big challenge, in general, is regulation,” he states.

“The challenge is that we cannot make claims, and that is, of course, a pity because we have unique benefits and we cannot claim it.”

However, the company has been tactical in how they can overcome the restrictions in the new market.

“The way we will overcome this, and what has been the underlining driver of Biogia’s success so far, is that we use a medical marketing model where we communicate through the medical professionals,” explains Sjöblad.

“So the medical professionals look at the clinical studies we have made, as we have always conducted these at the same level as if it was drug trials.”

“So we have extremely good clinical data, and this is used in the communication with medical professionals, and they in turn can recommend to the consumer, or this is instance the mother or father if they have a child with colic, them to go to the pharmacy and buy the drops.”

“The medical marketing model has been our way to reach out even if we cannot claim officially the benefit the product.”

BioGaia says that the Asia Pacific region, with Australia as one of its top markets, is one of the largest international probiotic markets and analysts have predicted that this region will retain its leading position in upcoming years.

According to Innova Market Insights, probiotic products in Australasia are on the rise, with probiotic product launches in the baby and toddler market rising by 10% from 2015 to 2016. The general dairy sector also saw a 14% rise in probiotic product launches during the same time period. 

BioGaia Probiotic Drops, as the product will be called in Australia, are planned to be launched mid 2017. Today the drops are sold in 70 countries worldwide. 

by Hannah Gardiner

Related Articles

Nutrition & Health News

AI: Nuritas explores potential health benefits during Future of Nutrition Summit

13 Dec 2017 --- Biotechnology company Nuritas has innovative plans for using artificial intelligence (AI) to relieve the potential burden of future global health issues. These plans were outlined during its Future of Nutrition Summit held the day before FiE 2017 in Frankfurt, during which Nuritas Commercial Manager Neil Foster outlined the company’s use of AI for data mining for bioactive peptides, specific molecules with “tremendous” health benefits.

Business News

Frutarom finalizes AB-Fortis micro-encapsulation technology acquisition

13 Dec 2017 --- Frutarom has acquired AB-Fortis activities, including a patent-protected micro-encapsulation technology that enables delivery of iron with increased biological absorption. Frutarom announced the signing of an agreement with AB-Biotics S.A. of Spain for the acquisition of the activity of AB-Fortis in November.

Business News

Kappa Bioscience moves to expand vitamin K2 presence in US with new appointments

13 Dec 2017 --- Kappa Bioscience AS, maker of K2Vital vitamin K2 MK-7, has appointed Garnet Pigden and New Jersey-based D2C to head-up the continued development of Kappa’s position in the US market. The appointment spans the establishment of strategy, infrastructure, partnerships and key accounts in support of an overall objective of solidifying vitamin K2 in mainstream US markets and channels, according to Kappa.

Nutrition & Health News

Researchers create app to predict and intervene in users' overeating

13 Dec 2017 --- Researchers at Worcester Polytechnic Institute (WPI) and the University of Connecticut (UConn) are collaborating on a smartphone app aimed at helping users manage their overeating challenges in three key ways: by tracking eating patterns, providing interventions and helping change behavior. According to the researchers, the app and its distinctive methodology have shown “tremendous promise” in an early pilot study.

Business News

Enzymotec and Frutarom merger gets shareholder green light

12 Dec 2017 --- The shareholders of Israeli specialty chemicals company Enzymotec Ltd. have approved by large majority the merger transaction between Frutarom and Enzymotec. The transaction was approved at Enzymotec’s General Meeting by 99.9 percent majority of shareholders present at the meeting and entitled to vote, Frutarom Industries Ltd. reports.

More Articles
URL : http://www.nutritioninsight.com:80/news/BioGaia-and-Nestl%C3%A9-Collaborate-to-Sell-BioGaia-Protectis-Drops-in-Australia.html?tracking=Home-Latest%20HeadLines&NewTracking=News